Changes could reduce compounding regulatory burden

The US Government is making moves to address drug shortages—which could have consequences for Australia Food and Drug Administration (FDA) Commissioner Scott Gottlieb has said his administration is looking to bolster the number of compounding pharmacies registering to become official ‘outsourcing facilities’. These facilities would be called on to manufacture pharmaceuticals during times of commercial

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Chemist Warehouse among Singles Day 'most-loved'
Next Fact Check: Do unemployed Aussies use more illicit drugs?